The Clorox Company $CLX Position Raised by Harbour Investments Inc.

Harbour Investments Inc. increased its position in shares of The Clorox Company (NYSE:CLX) by 123.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 10,646 shares of the company’s stock after buying an additional 5,890 shares during the quarter. Harbour Investments Inc.’s holdings in Clorox were worth $1,073,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Clorox by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares in the last quarter. Woodline Partners LP increased its holdings in shares of Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares in the last quarter. Baird Financial Group Inc. increased its holdings in shares of Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after buying an additional 424 shares in the last quarter. Jump Financial LLC increased its holdings in shares of Clorox by 173.5% in the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after buying an additional 7,924 shares in the last quarter. Finally, Bank of Nova Scotia increased its holdings in shares of Clorox by 26.2% in the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after buying an additional 3,352 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Trading Down 6.5%

NYSE CLX opened at $89.98 on Friday. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock has a market cap of $10.88 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 0.50 and a beta of 0.59. The firm’s 50 day moving average price is $98.46 and its two-hundred day moving average price is $105.81.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the previous year, the company posted $1.45 EPS. The company’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts anticipate that The Clorox Company will post 5.61 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have issued reports on CLX. Royal Bank Of Canada dropped their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. Rothschild & Co Redburn set a $117.00 price target on Clorox in a report on Friday, February 13th. UBS Group dropped their price target on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Evercore reaffirmed an “underperform” rating and issued a $110.00 price target on shares of Clorox in a report on Friday, May 1st. Finally, Jefferies Financial Group dropped their price target on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a report on Monday, May 4th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.